Symbols / LONA Stock $8.62 -5.90% LeonaBio, Inc.

Healthcare • Biotechnology • United States • NCM
LONA (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

LeonaBio, Inc., clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. Its product pipeline includes ATH-1105 for the treatment of amyotrophic lateral sclerosis, which is in phase 1 clinical trial; ATH-1020 for the treatment of neurodegenerative diseases, which is phase 1 clinical trial, as well as early compounds which is in preclinical phase. The company was formerly known as Athira Pharma, Inc. and changed its name to LeonaBio, Inc. in January 2026. LeonaBio, Inc. was incorporated in 2011 and is headquartered in Bothell, Washington.

Stock Fundamentals
Scroll to Statements
Market Cap 80.97M Enterprise Value -1.48M Income -105.61M Sales — Book/sh 2.98 Cash/sh 9.40
Dividend Yield — Payout 0.00% Employees 19 IPO — P/E — Forward P/E —
PEG — P/S — P/B 2.90 P/C — EV/EBITDA 0.04 EV/Sales —
Quick Ratio 1.86 Current Ratio 1.88 Debt/Eq 2.89 LT Debt/Eq — EPS (ttm) -24.70 EPS next Y —
EPS Growth — Revenue Growth — Earnings 2026-05-07 ROA -28.31% ROE -290.81% ROIC —
Gross Margin 0.00% Oper. Margin 0.00% Profit Margin 0.00% Shs Outstand 9.39M Shs Float 6.41M Short Float 1.82%
Short Ratio 1.09 Short Interest — 52W High 14.21 52W Low 2.30 Beta 2.23 Avg Volume 66.09K
Volume 58.28K Target Price $16.00 Recom Buy Prev Close $9.16 Price $8.62 Change -5.90%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$16.00
Mean price target
2. Current target
$8.62
Latest analyst target
3. DCF / Fair value
$43.05
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$8.62
Low
$16.00
High
$16.00
Mean
$16.00

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-02-19 up Mizuho Neutral → Outperform $10
News
RSS: Latest LONA news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-04 LITTON MARK JAMES Chief Executive Officer — 5,156 $5.37 $27,688
2026-03-04 SAN MARTIN JAVIER Officer — 1,720 $5.37 $9,236
2026-03-04 CHURCH KEVIN Officer — 1,359 $5.37 $7,298
2026-03-04 WORTHINGTON MARK General Counsel — 1,328 $5.37 $7,131
2026-03-04 RENNINGER ROBERT Chief Financial Officer — 906 $5.37 $4,865
2026-03-03 LITTON MARK JAMES Chief Executive Officer — 22,254 — —
2026-03-03 SAN MARTIN JAVIER Officer — 7,418 — —
2026-03-03 CHURCH KEVIN Officer — 5,856 — —
2026-03-03 WORTHINGTON MARK General Counsel — 5,726 — —
2026-03-03 RENNINGER ROBERT Chief Financial Officer — 3,900 — —
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.00
0.00
0.00
0.00
Operating Revenue
0.00
0.00
0.00
0.00
Operating Expense
34.18
-64.68%
96.78
-23.76%
126.94
+42.86%
88.86
Research And Development
17.50
-75.24%
70.68
-24.64%
93.79
+52.59%
61.46
Selling General And Administration
16.68
-36.08%
26.09
-21.65%
33.30
+2.31%
32.55
General And Administrative Expense
16.68
-36.08%
26.09
-21.65%
33.30
+2.31%
32.55
Other Gand A
16.68
-36.08%
26.09
-21.65%
33.30
+2.31%
32.55
Other Operating Expenses
—
—
-0.16
+96.96%
-5.16
Total Expenses
34.18
-64.68%
96.78
-23.76%
126.94
+42.86%
88.86
Operating Income
-34.18
+64.68%
-96.78
+23.76%
-126.94
-42.86%
-88.86
Total Operating Income As Reported
-102.27
-1.35%
-100.90
+19.58%
-125.47
-20.62%
-104.02
EBITDA
-33.21
+65.34%
-95.81
+23.94%
-125.97
-43.13%
-88.01
Normalized EBITDA
39.46
+143.04%
-91.68
+28.15%
-127.60
-63.56%
-78.01
Reconciled Depreciation
0.97
+0.21%
0.97
+0.10%
0.97
+14.67%
0.84
EBIT
-34.18
+64.68%
-96.78
+23.76%
-126.94
-42.86%
-88.86
Total Unusual Items
-72.67
-1660.77%
-4.13
-353.50%
1.63
+116.28%
-10.00
Total Unusual Items Excluding Goodwill
-72.67
-1660.77%
-4.13
-353.50%
1.63
+116.28%
-10.00
Special Income Charges
-68.09
-1549.82%
-4.13
-353.50%
1.63
+116.28%
-10.00
Other Special Charges
68.09
+1549.82%
4.13
+353.50%
-1.63
-116.28%
10.00
Net Income
-105.61
-8.94%
-96.94
+17.62%
-117.67
-23.04%
-95.64
Pretax Income
-105.61
-8.94%
-96.94
+17.62%
-117.67
-23.04%
-95.64
Net Non Operating Interest Income Expense
—
—
—
—
Interest Expense Non Operating
—
—
—
—
Net Interest Income
—
—
—
—
Interest Expense
—
—
—
—
Interest Income Non Operating
—
—
—
—
Interest Income
—
—
—
—
Other Income Expense
-71.43
-43191.52%
-0.17
-101.78%
9.27
+236.57%
-6.78
Other Non Operating Income Expenses
1.24
-68.80%
3.96
-48.12%
7.64
+137.47%
3.22
Gain On Sale Of Security
-4.58
—
—
—
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-105.61
-8.94%
-96.94
+17.62%
-117.67
-23.04%
-95.64
Net Income From Continuing Operation Net Minority Interest
-105.61
-8.94%
-96.94
+17.62%
-117.67
-23.04%
-95.64
Net Income From Continuing And Discontinued Operation
-105.61
-8.94%
-96.94
+17.62%
-117.67
-23.04%
-95.64
Net Income Continuous Operations
-105.61
-8.94%
-96.94
+17.62%
-117.67
-23.04%
-95.64
Normalized Income
-32.94
+64.51%
-92.81
+22.20%
-119.30
-39.31%
-85.64
Net Income Common Stockholders
-105.61
-8.94%
-96.94
+17.62%
-117.67
-23.04%
-95.64
Otherunder Preferred Stock Dividend
—
—
—
1.57
Diluted EPS
—
-25.20
+18.45%
-30.90
-22.13%
-25.30
Basic EPS
—
-25.20
+18.45%
-30.90
-22.13%
-25.30
Basic Average Shares
—
3.85
+1.21%
3.80
+0.76%
3.77
Diluted Average Shares
—
3.85
+1.21%
3.80
+0.76%
3.77
Diluted NI Availto Com Stockholders
-105.61
-8.94%
-96.94
+17.62%
-117.67
-23.04%
-95.64
Line Item Trend 2023-12-31
Total Assets
160.25
Current Assets
154.73
Cash Cash Equivalents And Short Term Investments
147.42
Cash And Cash Equivalents
90.58
Other Short Term Investments
56.84
Receivables
1.63
Other Receivables
1.63
Prepaid Assets
—
Other Current Assets
5.68
Total Non Current Assets
5.52
Net PPE
4.44
Gross PPE
6.77
Accumulated Depreciation
-2.33
Properties
0.00
Machinery Furniture Equipment
0.71
Construction In Progress
—
Other Properties
1.74
Leases
4.32
Investments And Advances
0.00
Other Non Current Assets
1.08
Total Liabilities Net Minority Interest
30.06
Current Liabilities
28.84
Payables And Accrued Expenses
23.93
Payables
0.13
Accounts Payable
0.13
Current Accrued Expenses
23.80
Pensionand Other Post Retirement Benefit Plans Current
4.54
Current Debt And Capital Lease Obligation
0.37
Current Capital Lease Obligation
0.37
Other Current Liabilities
—
Total Non Current Liabilities Net Minority Interest
1.22
Long Term Debt And Capital Lease Obligation
1.22
Long Term Capital Lease Obligation
1.22
Other Non Current Liabilities
—
Stockholders Equity
130.19
Common Stock Equity
130.19
Capital Stock
0.00
Common Stock
0.00
Share Issued
3.82
Ordinary Shares Number
3.82
Treasury Shares Number
0.00
Additional Paid In Capital
439.74
Retained Earnings
-309.21
Gains Losses Not Affecting Retained Earnings
-0.35
Other Equity Adjustments
-0.35
Total Equity Gross Minority Interest
130.19
Total Capitalization
130.19
Working Capital
125.89
Invested Capital
130.19
Total Debt
1.58
Capital Lease Obligations
1.58
Net Tangible Assets
130.19
Tangible Book Value
130.19
Investmentin Financial Assets
0.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-45.73
+52.94%
-97.17
+3.56%
-100.75
-39.03%
-72.47
Cash Flow From Continuing Operating Activities
-45.73
+52.94%
-97.17
+3.56%
-100.75
-39.03%
-72.47
Net Income From Continuing Operations
-105.61
-8.94%
-96.94
+17.62%
-117.67
-23.04%
-95.64
Depreciation Amortization Depletion
0.97
+0.21%
0.97
+0.10%
0.97
+14.67%
0.84
Depreciation
0.97
+0.21%
0.97
+0.10%
0.97
+14.67%
0.84
Depreciation And Amortization
0.97
+0.21%
0.97
+0.10%
0.97
+14.67%
0.84
Other Non Cash Items
67.93
+28087.55%
0.24
+12.62%
0.21
+5.42%
0.20
Stock Based Compensation
6.10
-44.77%
11.05
+4.01%
10.62
+0.16%
10.61
Operating Gains Losses
4.58
+65314.29%
0.01
—
—
Gain Loss On Investment Securities
4.58
—
—
—
Gain Loss On Sale Of PPE
0.00
-100.00%
0.01
0.00
—
Change In Working Capital
-19.38
-61.71%
-11.98
-283.58%
6.53
-45.33%
11.94
Change In Receivables
0.00
-100.00%
1.63
+505.99%
-0.40
-136.16%
1.11
Change In Prepaid Assets
2.44
-2.79%
2.51
+2320.35%
-0.11
+91.01%
-1.26
Change In Payables And Accrued Expense
-21.34
-35.50%
-15.75
-313.80%
7.37
-39.12%
12.10
Change In Accrued Expense
0.00
+100.00%
-10.00
0.00
-100.00%
10.00
Change In Payable
-21.34
-271.10%
-5.75
-178.06%
7.37
+250.64%
2.10
Change In Account Payable
-21.34
-271.10%
-5.75
-178.06%
7.37
+250.64%
2.10
Change In Other Current Liabilities
-0.47
-28.53%
-0.37
-12.88%
-0.33
-2073.33%
-0.01
Investing Cash Flow
-15.89
-128.99%
54.83
-42.34%
95.09
+64.90%
57.66
Cash Flow From Continuing Investing Activities
-15.89
-128.99%
54.83
-42.34%
95.09
+64.90%
57.66
Net PPE Purchase And Sale
0.00
+100.00%
-0.03
+89.14%
-0.30
+73.36%
-1.14
Purchase Of PPE
0.00
+100.00%
-0.03
+89.14%
-0.30
+73.36%
-1.14
Capital Expenditure
—
-0.03
+89.14%
-0.30
+73.36%
-1.14
Net Investment Purchase And Sale
-15.89
-128.97%
54.86
-42.49%
95.39
+62.22%
58.80
Purchase Of Investment
-37.64
-166.33%
-14.13
+48.92%
-27.67
+70.96%
-95.29
Sale Of Investment
21.75
-68.48%
69.00
-43.93%
123.06
-20.14%
154.09
Financing Cash Flow
82.46
+42405.67%
0.19
-60.65%
0.49
-24.62%
0.65
Cash Flow From Continuing Financing Activities
82.46
+42405.67%
0.19
-60.65%
0.49
-24.62%
0.65
Net Issuance Payments Of Debt
—
—
—
—
Issuance Of Debt
—
—
—
—
Long Term Debt Issuance
—
—
—
—
Net Long Term Debt Issuance
—
—
—
—
Net Common Stock Issuance
—
—
—
0.00
Proceeds From Stock Option Exercised
0.04
-80.93%
0.19
-60.65%
0.49
-24.62%
0.65
Net Other Financing Charges
82.42
—
—
—
Changes In Cash
20.84
+149.44%
-42.15
-715.05%
-5.17
+63.46%
-14.15
Beginning Cash Position
49.07
-46.21%
91.22
-5.36%
96.39
-12.80%
110.54
End Cash Position
69.91
+42.47%
49.07
-46.21%
91.22
-5.36%
96.39
Free Cash Flow
-45.73
+52.96%
-97.20
+3.81%
-101.06
-37.29%
-73.61
Amortization Of Securities
-0.33
+36.12%
-0.52
+63.58%
-1.41
-235.07%
-0.42
Common Stock Issuance
—
—
—
0.00
Issuance Of Capital Stock
—
—
—
0.00
Net Preferred Stock Issuance
—
—
—
—
Preferred Stock Issuance
—
—
—
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category